Approximately 570,000 doses available across 17 states through latest allocation
WOONSOCKET, R.I. — CVS Health (NYSE: CVS) has added Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where select CVS Pharmacy locations will offer COVID-19 vaccinations to eligible populations through the Federal Retail Pharmacy Program. This follows the successful February 12 rollout in 11 states: California, Connecticut, Hawaii, Maryland, Massachusetts, New Jersey, New York, Rhode Island, South Carolina, Texas, and Virginia. Appointments for the latest allocation of approximately 570,000 doses will start to become available for booking today, with shots beginning February 25.
"Feedback on every aspect of the vaccination process has been incredibly positive, from the digital experience to interacting with our team of health care professionals," said Karen S. Lynch, President and Chief Executive Officer, CVS Health. "We're also making significant progress in reaching vulnerable communities, which will continue to be an essential part of our vaccination effort."
There are nearly 10,000 CVS Pharmacy locations nationwide, with almost half located in communities ranked high or very high in the Centers for Disease Control and Prevention Social Vulnerability Index (SVI). High SVI rank, along with population density and area demographics, are critical factors when determining which CVS Pharmacy locations will offer COVID-19 vaccinations. CVS Health recently announced several steps to address vaccine education and equity, in particular among Black and Hispanic populations.
CVS Health has been offering COVID-19 vaccines on a limited basis in Ohio using state allocations. As more supply becomes available through the federal program, the company will expand to additional states while increasing the number of stores offering vaccinations. CVS Pharmacy has the capacity to administer 20 25 million shots per month.
Vaccines in a retail setting are offered on an appointment-only basis via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: 1-800-746-7287.
Long-term care vaccination effort nearing completion
CVS Health has administered approximately four million COVID-19 vaccine doses to residents and staff in over 40,000 long-term care facilities across the country through the Pharmacy Partnership for Long-Term Care Program. CVS Pharmacy teams have completed second doses at all skilled nursing facilities and will complete second doses at assisted living and other facilities by mid-March,Excludes facilities that 1) requested a later date due to a COVID-19 outbreak or other reason, 2) were rescheduled due to lack of responsiveness, or 3) requested to be added to the program after the start date or did not meet original program criteria regarding distance from CVS Pharmacy locations, but CVS Health has opted to support. delivering on the company's commitment to help protect a population disproportionately impacted by the pandemic. CVS Health has been regularly updating its progress through publicly available data.
Multimedia assets, including b-roll and still photography from long-term care facility and in-store COVID-19 vaccinations, are available here. More information on steps CVS Health has taken to address the pandemic is available at the company's frequently updated COVID-19 resource center.
About CVS Health
CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.
Cautionary Statement Concerning Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward Looking Statements" in our most recently filed Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020. You are cautioned not to place undue reliance on CVS Health's forward looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.
Media contact
T.J. Crawford
212-457-0583
crawfordt2@aetna.com